| Range of results prior to case-mix adjustment | Number of networks significantly different to baseline network | |||
| Lowest network (%) | Highest network (%) | Before adjustment | After adjustment | |
| Histological diagnosis (NSCLC) | 39.6 | 88.5 | 24 (73%) | 24 (73%) |
| Anti-cancer treatment (NSCLC) | 17.8 | 67.4 | 21 (64%) | 20 (61%) |
| Surgery (NSCLC) | 3.6 | 37.2 | 17 (52%) | 18 (55%) |
| Chemotherapy (SCLC) | 18.2 | 85.2 | 12 (36%) | 13 (39%) |
NSCLC, non-small cell lung cancer; SCLC, small cell lung cancer.